
The Clinical Trial Design

WEST
From July 2018 to January 2020, a prospective randomized controlled trial of analgesia management using ropivacaine for ACB + GA after “3‐in‐1” procedure surgery for RPD was conducted at the Department of Sports Medicine, West China Hospital of Sichuan University. All procedures described in this study were registered with the Chinese Clinical Trial Registry (ChiCTR2000032484) and approved by Biomedical Ethics Committee, West China Hospital of Sichuan University (No. 2018‐034). Inclusion criteria were as follows: 14–60 years old, no gender limitation, growth plate closed, American Society of Anesthesiologists (ASA) physical classification I to II, body mass index (BMI) less than 35 kg/mConsolidated Standards of Reporting Trial (CONSORT) diagram of patient flow through the study